Dr. Agne Alminaite

Dr. Agne Alminaite has studied Molecular Biology in Vilnius University (Lithuania) and earned her Ph.D. in Virology from the Faculty of Medicine, University of Helsinki (Finland). She moved to work as a scientific consultant for the International Potato Center in Lima, Peru. In 2011 Agne joined Thermo Fisher Scientific and after several years in R&D advanced to the role in product management. She is currently the Product Manager for Custom Molecular Biology Products, taking care of the portfolio that includes all the isothermal amplification enzymes, Phi29, the Phi29 polymerase mutant - Equiphi29 and the Bst DNA polymerase as well as broad spectrum of enzymes for DNA and RNA modification, NGS and cloning.

Got a question for Dr. Agne Alminaite?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 1

Webinar

Enzymes for Advancing Point-of-Care Diagnostics

Point-of-care testing is the future of diagnostic solutions. The main reason for this is point-of-care testing is robust, easy to use and provides immediate results and thus allows treatment decisions to be made more quickly. As an additional benefit, point-of-care diagnostic testing brings value to patients and healthcare systems.

We are here to help progress point-of-care diagnostics with our glycerol-free enzymes. Lyo-ready enzymes are as efficient and as high in performance as traditional formats of enzymes and this new formulation is suitable for use in microfluidics instruments.